1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kazakhstan Pharmaceuticals and Healthcare Report Q4 2016

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 75 pages

Includes 3 FREE quarterly updates

BMI View:

The implementation of a new health insurance scheme, as well as policies to stabilise medicine prices and increase accessibility of drugs, will boost pharmaceutical sales in Kazakhstan. Furthermore, the stabilisation of the tenge and improved outlook of the Kazakh economy will bolster foreign import sales. We believe Kazakhstan will remain a bright spot for multinational drugmakers in the Commonwealth of Independent States (CIS), and Central and Eastern Europe (CEE) region as a whole. However, Weak IP laws and a growing preference for generic drugs will limit the potential of innovative medicine sales.


Headline Expenditure Projections

- Pharmaceuticals: KZT350bn (USD1.57bn) in 2015 to KZT379bn (USD1.12bn) in 2016; +8.4% in local currency terms and -28.5% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: KZT1.84trn (USD8.27bn) in 2015 to KZT2.08trn (USD6.14bn) in 2016; +12.6% in local currency terms and -25.7% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kazakhstan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 18
Prescription Drug Market 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 25
OTC Drug Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2014-2020) 31
Industry Risk/Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q4 2016 32
Kazakhstan Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 42
Pricing And Reimbursement Regime 43
Market Overview 47
Healthcare Sector 48
Clinical Trials 50
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Multinational Market Activity 57
Pharmaceutical Distribution 58
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2016$$
Pharmaceutical Retail Sector 59
Company Profile 60
Chimpharm 60
Romat 62
Demographic Forecast 64
Demographic Outlook 64
Table: Population Headline Indicators (Kazakhstan 1990-2025) 65
Table: Key Population Ratios (Kazakhstan 1990-2025) 65
Table: Urban/Rural Population and Life Expectancy (Kazakhstan 1990-2025) 66
Table: Population By Age Group (Kazakhstan 1990-2025) 66
Table: Population By Age Group % (Kazakhstan 1990-2025) 67
Glossary 69
Methodology 71
Pharmaceutical Expenditure Forecast Model 71
Healthcare Expenditure Forecast Model 71
Notes On Methodology 72
Risk/Reward Index Methodology 73
Index Overview 74
Table: Pharmaceutical Risk/Reward Index Indicators 74
Indicator Weightings 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.